Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AUPH

Aurinia Pharmaceuticals Inc

May 29 • 04:00PM ET

15.33

-0.02 -0.13 %

Healthcare • Biotechnology • Canada • Small • NASD

Peers: MIRM PTCT RYTM VKTX BMRN INCY KRYS AXSM NBIX PHVS

| Held by: IWM IWO IBB VTWO JSMD VHT FESM AVSC JSML SPDW

Scroll to Statements

Index	RUT	P/E	7.09	EPS (ttm)	2.16	Insider Own	11.71%	Shs Outstand	130.77M	Perf Week	-0.78%
Market Cap	1.97B	Forward P/E	13.75	EPS next Y	1.11	Insider Trans	6.36%	Shs Float	113.54M	Perf Month	0.33%
Enterprise Value	1.66B	PEG	-	EPS next Q	0.23	Inst Own	61.06%	Short Float	7.95%	Perf Quarter	8.19%
Income	298.21M	P/S	6.61	EPS this Y	-55.88%	Inst Trans	1.51%	Short Ratio	7.63	Perf Half Y	-5.84%
Sales	298.30M	P/B	3.53	EPS next Y	22.08%	ROA	48.54%	Short Interest	9.02M	Perf YTD	-3.89%
Book/sh	4.34	P/C	5.20	EPS next 5Y	-13.42%	ROE	64.98%	52W High	16.88 -9.18%	Perf Year	91.86%
Cash/sh	2.95	P/FCF	11.81	EPS past 3/5Y	- -	ROIC	48.24%	52W Low	7.28 110.43%	Perf 3Y	61.54%
Dividend Est.	-	EV/EBITDA	11.12	Sales past 3/5Y	28.30% 41.38%	Gross Margin	89.74%	Volatility	3.25% 3.87%	Perf 5Y	5.58%
Dividend TTM	-	EV/Sales	5.57	EPS Y/Y TTM	696.05%	Oper. Margin	43.58%	ATR (14)	0.57	Perf 10Y	509.49%
Dividend Ex-Date	-	Quick Ratio	5.01	Sales Y/Y TTM	20.62%	Profit Margin	99.97%	RSI (14)	46.87	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.55	EPS Q/Q	53.13%	SMA20	-1.66%	Beta	1.42	Target Price	17.00
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	24.40%	SMA50	-1.05%	Rel Volume	1.10	Prev Close	15.35
Employees	128	LT Debt/Eq	0.09	Earnings	May 07 BMO	SMA200	7.07%	Avg Volume	1.18M	Price	15.33
IPO	Oct 20, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.21% 0.94%	Trades		Volume	1,304,155	Change	-0.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)